Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
Australasian Radiology
|
August 2, 2003
A prospective trial of short-fractionation radiotherapy for the palliation of liver metastases
S Bydder, N A Spry, D R H Christie, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 19, 2018
Patterns of Failure Following Dose-escalated Chemoradiotherapy for Fluorodeoxyglucose Positron Emission Tomography Staged Squamous Cell Carcinoma of the Oesophagus
R Effeney, T Shaw, B H Burmeister, et al.
Head & Neck
|
November 15, 2011
Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy
Sandro V Porceddu, David I Pryor, Elizabeth Burmeister, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 1, 1996
Factors influencing outcome following radio-chemotherapy for oesophageal cancer. The Trans Tasman Radiation Oncology Group (TROG)
J W Denham, B H Burmeister, D S Lamb, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 27, 2010
T1-2 anal carcinoma requires elective inguinal radiation treatment--the results of Trans Tasman Radiation Oncology Group study TROG 99.02
John H L Matthews, Bryan H Burmeister, Martin Borg, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 15, 1995
Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicenter study
B H Burmeister, J W Denham, M O'Brien, et al.
The British Journal of Surgery
|
February 5, 2004
Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy
W A Brown, J Thomas, D Gotley, et al.
Diseases of the Colon and Rectum
|
May 21, 2005
Promising results of a cooperative group phase II trial of preoperative chemoradiation for locally advanced rectal cancer (TROG 9801)
Samuel Y K Ngan, Richard Fisher, Bryan H Burmeister, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 19, 2010
Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial
Bryan H Burmeister, Janine M Thomas, Elizabeth A Burmeister, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
October 26, 2007
Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapy
B M Smithers, M Cullinan, J M Thomas, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
Australasian Radiology
|
August 2, 2003
A prospective trial of short-fractionation radiotherapy for the palliation of liver metastases
S Bydder, N A Spry, D R H Christie, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 19, 2018
Patterns of Failure Following Dose-escalated Chemoradiotherapy for Fluorodeoxyglucose Positron Emission Tomography Staged Squamous Cell Carcinoma of the Oesophagus
R Effeney, T Shaw, B H Burmeister, et al.
Head & Neck
|
November 15, 2011
Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy
Sandro V Porceddu, David I Pryor, Elizabeth Burmeister, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 1, 1996
Factors influencing outcome following radio-chemotherapy for oesophageal cancer. The Trans Tasman Radiation Oncology Group (TROG)
J W Denham, B H Burmeister, D S Lamb, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 27, 2010
T1-2 anal carcinoma requires elective inguinal radiation treatment--the results of Trans Tasman Radiation Oncology Group study TROG 99.02
John H L Matthews, Bryan H Burmeister, Martin Borg, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 15, 1995
Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicenter study
B H Burmeister, J W Denham, M O'Brien, et al.
The British Journal of Surgery
|
February 5, 2004
Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy
W A Brown, J Thomas, D Gotley, et al.
Diseases of the Colon and Rectum
|
May 21, 2005
Promising results of a cooperative group phase II trial of preoperative chemoradiation for locally advanced rectal cancer (TROG 9801)
Samuel Y K Ngan, Richard Fisher, Bryan H Burmeister, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 19, 2010
Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial
Bryan H Burmeister, Janine M Thomas, Elizabeth A Burmeister, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
October 26, 2007
Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapy
B M Smithers, M Cullinan, J M Thomas, et al.
Page
of 8